Aztreonam-avibactam synergy, a validation and comparison of diagnostic tools
Frontiers in Microbiology · 29.11.2023 · 14
DOI: 10.3389/fmicb.2023.1322180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 29.11.2023. Verfasst von Gil Verschelden und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Antimicrobial resistance is a growing problem that necessitates the development of new therapeutic options. Cefiderocol and aztreonam (AT) are often the last active β-lactams for treating metallo-β-lactamases (MBL)-producing Gram-negative bacilli. In these difficult-to-treat bacterial strains, AT resistance is frequently attributed to the co-occurrence of other resistance mechanisms. In the case of β-lactamases they can often be inhibited by avibactam. In the present study, we evaluated the use of the double-disc synergy test (DDST) as a screening tool for the detection of synergy between AT-avibactam (ATA). We validated both the Gradient Diffusion Strips (GDSs) superposition method and the commercially available Liofilchem’s ATA GDS. Materials and methods We tested AT susceptibility in combination with ceftazidime-avibactam for 65 strains, including 18 Serine-β-Lactamase (SBL)- and 24 MBL-producing Enterobacterales , 12 MBL-producing P. aeruginosa , and 11 S. maltophilia isolates. Interpretation was done with EUCAST breakpoints (version 13.0), AT breakpoints being used for ATA. The accuracy and validity of the GDSs superposition method and ATA GDS were evaluated using an AT GDS applied on Mueller Hinton Agar plates supplemented with avibactam (MH-AV). A DDST was performed to screen for synergy between antibiotic combinations.
Results
Using MH-AV, all SBL- and MBL-positive Enterobacterales were susceptible or susceptible at increased exposure to the combination AT-avibactam. In contrast, only 2 out of the 12 (17%) P. aeruginosa strains and 9/11 (82%) of the S. maltophilia strains were susceptible- or susceptible at increased exposure for the combination of AT-avibactam. The DDST detected all synergies, demonstrating a 100% sensitivity and 100% negative predictive value for all bacterial strains.
Conclusion
The DDST is a sensitive tool for screening for antibiotic synergy. Unlike S. maltophilia and SBL- and MBL-positive Enterobacterales , most MBL-positive P. aeruginosa strains remain resistant to AT-avibactam. ATA GDS should be preferred for MIC determination of the AT-avibactam combination, while the GDSs superposition method can be used as an alternative to the commercial test.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
- Department of Microbiology and Infection Control, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
- Translational Oncology, University Medical Center Augsburg, Augsburg, Germany.
- AIMS Lab, Center for Neurosciences, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Zitieren
APA
Verschelden, G., Noeparast, M., Stoefs, A., Van Honacker, E., Vandoorslaer, K., Vandervore, L., Olbrecht, M., Van Damme, K., Demuyser, T., Piérard, D., & Wybo, I. (2023). Aztreonam-avibactam synergy, a validation and comparison of diagnostic tools. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1322180
Vancouver
Verschelden G, Noeparast M, Stoefs A, Van Honacker E, Vandoorslaer K, Vandervore L, et al. Aztreonam-avibactam synergy, a validation and comparison of diagnostic tools. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1322180
BibTeX
@article{Verschelden2023,
author = {Verschelden, Gil and Noeparast, Maxim and Stoefs, Anke and Van Honacker, Eveline and Vandoorslaer, Kristof and Vandervore, Laura and Olbrecht, Margo and Van Damme, Kathleen and Demuyser, Thomas and Piérard, Denis and Wybo, Ingrid},
title = {Aztreonam-avibactam synergy, a validation and comparison of diagnostic tools},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1322180}
}
EUVIMED